Doms № 1 -2022

Doms № 1 -2022 (29-36 p)

Depression in patients with diabetes mellitus
Mankovsky B. M.

Abstract

The problem of interrelationship between diabetes mellitus and depression has drown interest recently, but connection between two illnesses had been noticed a long time ago. In the 17th century a prominent English teacher and doctor Thomas Willis had written that among quiet people, they experienced grief and confusion by stretching the trivial hour, growing risk of developing for diabetes mellitus. Naturally, in our days we don’t talk about the direct etiological role of depression in the development of diabetes, but the link between two diseases had been well established. Currently, there are no universally recognized international or national recommendations, dedicated to specific treatment issues of people with diabetes and depression. Treating patients with a combination of diabetes mellitus and depression should be given the same attention to the correction of depression symptoms (by the use of appropriate psychological approaches and treatment with medication) and achievement diabetes compensation. A certain thing, the priority points at these should be suicidal warnings attempts, elimination of symptoms of depression and achievement remission of depression. The treatment of people with diabetes mellitus and depression should not delay, and relay only on doctors — endocrinologists, therapists or specialists in family medicine. These patients instead should be referred for examination and further treatment to specialized psychiatric hospitals or departments.

Keywords: diabetes mellitus, depression, Thomas Willis, suicidal attempts.

References

  1. American Diabetes Association. Standards of Medical Care in Diabetes. Diabetes Care. 2021; 44, Supplement 1: S1-S232.
  2. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care. 2001;24(6):1069-1078.
  3. Dibato JE , Montvida O, Zaccardi F et al. Association of Car- diometabolic Multimorbidity and Depression With Cardio-vascular Events in Early-Onset Adult Type 2 Diabetes: A Multiethnic Study in the U.S. Diabetes Care. 2021;44(1):231-239.
  4. Elamoshy R, Bird Y, Thorpe L, Moraros J. Risk of Depression and Suicidality among Diabetic Patients: A Systematic Review and Meta-Analysis. J Clin Med. 2018;7(11):445. doi: 10.3390/jcm7110445.
  5. van der Feltz-Cornelis C, Allen SF, Holt RIG, et al. Treatment
    for comorbid depressive disorder or subthreshold depression in diabetes mellitus: Systematic review and meta-analysis. Brain Behav. 2021;11(2):e01981. doi: 10.1002/brb3.1981. Epub 2020 Dec 4.
  6. Fisher L, Hessler DM, Polonsky WH, et al. Prevalence of depression in type 1 diabetes and the problem of over- diagnosis. Diabet Med. 2016;33(11): 1590–1597.
  7. Geraets AFJ, Köhler S, Muzambi R, et al. The association of hyperglycaemia and insulin resistance with incident depressive symptoms over 4 years of follow-up: The Maastricht Study. Diabetologia. 2020;63(11):2315-2328.
  8. Gonzalez JS, Peyrot M, McCarl LA, et al. Depression and diabetes treatment nonadherence: a meta-analysis. Diabetes Care. 2008;31(12):2398-2403.
  9. Holt RIG (2019) Diabetes, Depression, and Cognitive Disorders. In: E. Bonora, R. DeFronzo (eds.), Diabetes Complications, Comorbidities and Related Disorders, Endocrinology, Springer, Cham. https://doi.org/10.1007/978-3-319-27316- 7_24-2
  10. Holt RI, de Groot M, Lucki I, et al. NIDDK international conference report on diabetes and depression: cur- rent understanding and future directions. Diabetes Care. 2014;37(8):2067-2077.
  11. Kessing LV, Rytgaard HC, Ekstrøm CT, et al. Antidiabetes Agents and Incident Depression: A Nationwide Population- Based Study. Diabetes Care. 2020;43(12):3050-3060.
  12. Nouwen A, Nefs G, Caramlau I, et al. Prevalence of depression in individuals with impaired glucose metabolism or undiagnosed diabetes: a systematic review and meta-analysis of the European Depression in Diabetes (EDID) Research Consortium. Diabetes Care. 2011; 34(3):752–762.
  13. Lloyd CE, Sartorius N, Ahmed HU, et al. Factors associated with the onset of major depressive disorder in adults with type 2 diabetes living in 12 different countries: results from the INTERPRET-DD prospective study. Epidemiol Psychiatr Sci. 2020 Jun 2;29:e134. doi: 10.1017/S2045796020000438.
  14. Lloyd CE, Sartorius N, Cimino LC, et al. The INTERPRET- DD study of diabetes and depression: a protocol. Diabet Med. 2015;32(7):925-934.
  15. Moulton CD, Pickup JC, Ismail K. The link between depression and diabetes: the search for shared mechanisms. Lancet Diabetes Endocrinol. 2015;3(6):461-471.
  16. Da Silva AM, Fournier A, Boutron-Ruault MC, et al. In- creased risk of type 2 diabetes in antidepressant users: evi- dence from a 6-year longitudinal study in the E3N cohort. Diabet Med. 2020;37(11):1866-1873.
  17. Sturt J, Dennick K, Due-Christensen M, McCarthy K. The detection and management of diabetes distress in people with type 1 diabetes. Curr Diab Rep. 2015;15(11):101. doi: 10.1007/s11892-015-0660-z.
  18. Sun JC, Xu M, Lu JL, et al. Associations of depression with impaired glucose regulation, newly diagnosed diabetes and previously diagnosed diabetes in Chinese adults. Diabet Med. 2015;32(7):935-943.
  19. Watson KT, Simard JF, Henderson VW, et al. Association of Insulin Resistance With Depression Severity and Remission Status: Defining a Metabolic Endophenotype of Depression. JAMA Psychiatry. 2020:e203669. doi: 10.1001/jamapsychiatry.2020.3669. Online ahead of print.
  20. Zghebi SS, Steinke DT, Rutter MK, Ashcroft DM. Eleven-year multimorbidity burden among 637 255 people with and without type 2 diabetes: a population-based study using primary care and linked hospitalisation data. BMJ Open. 2020;10(7):e033866. doi: 10.1136/bmjopen-2019-033866.

Received: 20.12.2021

Revised: 10.01.2022

Accepted: 20.01.2022